Premier (NASDAQ:PINC) Stock, Quote.Headers.trade-ideas

Premier

Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.

Ardelyx ARDX

Large Cap

News

Health Care

Legal

General

PINC

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation

premier Health-Wikimedia Commons

Earnings

Guidance

Buybacks

Movers

Trading Ideas

Premier charts a strategic path with a $1.0 billion share repurchase plan through June 2025. Q2 2024 earnings: EPS $0.60, sales $334.75 million

Healthcare Purchasing Network Premier Launches $1B Share Buyback Program, Concludes Strategic Review Process After Q2 Performance

Dividends

Price Target

Markets

Analyst Ratings

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a  high dividend payout. 

Wall Street&#39;s Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields

Premier Inc

<p>JP Morgan  analyst Anne Samuel   maintains Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Neutral and lowers the price target from $21 to $19.</p>


JP Morgan Maintains Neutral on Premier, Lowers Price Target to $19

<p>Benchmark  analyst Bill Sutherland   downgrades Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) from Buy to Hold.</p>


Downgrades

Benchmark Downgrades Premier to Hold

<p>Canaccord Genuity  analyst Richard Close   maintains Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Hold and lowers the price target from $21 to $20.</p>


Canaccord Genuity Maintains Hold on Premier, Lowers Price Target to $20

<p>Baird  analyst Eric Coldwell   maintains Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Neutral and lowers the price target from $22 to $19.</p>


Baird Maintains Neutral on Premier, Lowers Price Target to $19

<p>Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.49 by 40.82 percent. This is a 2.99 percent increase over earnings of $0.67 per share from the same period last year.  The company reported quarterly sales of $350.27 million which beat the analyst consensus estimate of $313.21 million by 11.83 percent.  This is a 2.91 percent increase over sales of $340.36 million the same period last year.</p>


Earnings Beats

Premier Q4 Adj $0.69 Beats $0.49 Estimate, Sales $350.27M Beat $313.21M Estimate

<p>Coleman will succeed Craig McKasson, who will retire on December 31, 2024, and will serve as a strategic advisor to the company through 2026.</p>


Management

Premier, Inc. Names Glenn Coleman As The Chief Administrative And Financial Officer, Effective November 11, 2024

<ul>
<li><i>Partnership to support more than $3.5 billion in AllSpire annual GPO purchasing volume.</i></li>
<li><i>Premier supply chain services and performance improvement technology to enable operational efficiency, supply chain innovation and value​ for AllSpire members.</i></li>
</ul>


Contracts

AllSpire Health Partners Selects Premier As National GPO

<p>Teleflex Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFX#NYSE">TFX</a>), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS&reg; Hemostasis Products agreements allow Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex products within the hemostatic portfolio.<br />
&nbsp;</p>
<p>Premier&#39;s SURPASS&reg; program is designed to drive the highest-level commitment and savings for members through aggregated purchasing of high-quality products and services. The program brings together Premier&#39;s most committed members to coordinate purchasing decisions and maintain standardization across their facilities. By providing additional value to Premier contracted suppliers through volume and commitment, the program is expected to achieve best-in-market pricing.</p>
<p>QuikClot&trade; Hemostatic Dressings and Devices control bleeding faster than standard gauze or laparotomy pads,1-3&nbsp;enabling clinicians to move patients to the next stage of care quickly. The portfolio includes a range of products to support clinicians throughout the hospital, including in the Emergency Department, Operating Room, Intensive Care Unit, and Catheterization Lab.</p>


Teleflex Secures Premier Agreements for Hemostasis Products with Special Pricing

<p>Analysts' ratings for Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $21.5, a high estimate of $22.00, and a low estimate of $21.00. Experiencing a 13.13% decline, the current average is now lower than the previous average price target of $24.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1716922860_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Premier among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anne Samuel</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$21.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Premier. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Premier compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Premier's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Premier's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PINC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Premier analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know Premier Better</h2>
<p>Premier Inc is a Charlotte, North Carolina-based national group purchasing organization providing primary supply chain services to large hospital systems and more recently to alternate outpatient locations as it expands its footprint. Through acquisitions, the company also offers a compliment of advisory services and consulting services along with software-as-a-service-based subscriptions. The company's revenue is all sourced domestically and is reported in two business segments: the core supply chain services (approximately 70% of fiscal 2019 revenue) and the consulting and technology platform of performance services (approximately 30%).</p>
<h3>Key Indicators: Premier's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Premier showcased positive performance, achieving a revenue growth rate of <strong>6.32%</strong> as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Premier's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-11.73%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Premier's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-1.86%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-1.12%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.07</strong>, Premier adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Decoding 4 Analyst Evaluations For Premier

<p>JP Morgan  analyst Anne Samuel   maintains Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Neutral and lowers the price target from $23 to $21.</p>


JP Morgan Maintains Neutral on Premier, Lowers Price Target to $21

<p>In the preceding three months, 4 analysts have released ratings for Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Premier and provided 12-month price targets. The average target is $21.88, accompanied by a high estimate of $22.50 and a low estimate of $21.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.62%. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715187623_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The perception of Premier by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$21.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Michael Cherny</td>
<td>Leerink Partners</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$22.50</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Premier. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Premier compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Premier's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Premier's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PINC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Premier analyst ratings.</strong></a></p>
<h2>Get to Know Premier Better</h2>
<p>Premier Inc is a Charlotte, North Carolina-based national group purchasing organization providing primary supply chain services to large hospital systems and more recently to alternate outpatient locations as it expands its footprint. Through acquisitions, the company also offers a compliment of advisory services and consulting services along with software-as-a-service-based subscriptions. The company's revenue is all sourced domestically and is reported in two business segments: the core supply chain services (approximately 70% of fiscal 2019 revenue) and the consulting and technology platform of performance services (approximately 30%).</p>
<h3>Premier: A Financial Overview</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Premier's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately <strong>-6.92%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Premier's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>16.22%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Premier's ROE excels beyond industry benchmarks, reaching <strong>2.29%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Premier's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.41%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Premier's debt-to-equity ratio is below the industry average. With a ratio of <b>0.07</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Unveiling 4 Analyst Insights On Premier

<p>Piper Sandler  analyst Jessica Tassan   maintains Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Neutral and lowers the price target from $24 to $22.</p>


Piper Sandler Maintains Neutral on Premier, Lowers Price Target to $22

<p>Canaccord Genuity  analyst Richard Close   downgrades Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) from Buy to Hold and lowers the price target from $27 to $21.</p>


Canaccord Genuity Downgrades Premier to Hold, Lowers Price Target to $21

<p>Baird  analyst Eric Coldwell   maintains Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Neutral and lowers the price target from $25 to $22.</p>


Baird Maintains Neutral on Premier, Lowers Price Target to $22

Premier Sees FY24 Total Net Revenue Of $1.265B-$1.325B Vs. $1.3B estimate; Maintains Adjusted EPS Outlook Of $2.06-$2.18 Vs. $2.15 Estimate

Premier Executed $400M  Accelerated Share Repurchase Transaction During Q3, Which Will Be Fully Settled By Q1 Fiscal 2025

<p>Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.48 by 14.58 percent. This is a 5.17 percent decrease over earnings of $0.58 per share from the same period last year.  The company reported quarterly sales of $342.60 million which beat the analyst consensus estimate of $318.51 million by 7.56 percent.  This is a 6.32 percent increase over sales of $322.23 million the same period last year.</p>


Premier Q3 Adj $0.55 Beats $0.48 Estimate, Sales $342.60M Beat $318.51M Estimate

<p><a href="https://premierinc.com/newsroom/press-releases/premier-inc-announces-strategic-supply-chain-partnership-with-beebe-healthcare">https://premierinc.com/newsroom/press-releases/premier-inc-announces-strategic-supply-chain-partnership-with-beebe-healthcare</a></p>
<p>&nbsp;</p>


Beebe Healthcare Selects Premier As Supply Chain Operations Strategic Partner

<p><a href="https://premierinc.com/newsroom/press-releases/clinical-research-collaboration-between-premier-inc-s-pinc-ai-applied-sciences-and-mclaren-health-care-aims-to-advance-patient-outcomes">https://premierinc.com/newsroom/press-releases/clinical-research-collaboration-between-premier-inc-s-pinc-ai-applied-sciences-and-mclaren-health-care-aims-to-advance-patient-outcomes</a></p>
<p>&nbsp;</p>


'Clinical Research Collaboration Between Premier, Inc.'s PINC AI Applied Sciences And McLaren Health Care Aims To Advance Patient Outcomes' - Premier

<p>Leerink Partners  analyst Michael Cherny   initiates coverage on Premier (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PINC#NASDAQ">PINC</a>) with a Market Perform rating and announces Price Target of $22.5.</p>


Initiation

Leerink Partners Initiates Coverage On Premier with Market Perform Rating, Announces Price Target of $22.5

Premier (PINC) just unveiled an announcement. In a recent press release dated August 20, 2024, significant management changes within the company we...

Premier Announces Major Management Changes in Press Release

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Premier</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pinc-stock-quote/"><strong>PINC</strong></a></span>) just reported results for the fourth quarter of 2024.</p><ul><li>Premier reported earnings per share of 69 cents. This was above the analyst estimate for EPS of 49 cents.</li><li>The company reported revenue of $350.27 million.</li><li>This was 11.83% better than the analyst estimate for revenue of $313.21 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/pinc-stock-earnings-premier-for-q4-of-2024/">PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q4 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q4 2024

Premier (PINC) Q4 2024 Earnings Call Transcript

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Premier (PINC – Research Report) and Veeva Systems (VEEV – Resear...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Premier (PINC) and Veeva Systems (VEEV)

Premier (PINC) just unveiled an announcement. On August 20, 2024, the Company provided insights into its financial performance for the last quarter...

Premier's Financial Performance and Strategy Update

Leerink Partners analyst Michael Cherny maintained a Hold rating on Premier (PINC – Research Report) on August 20 and set a price target of $20.00....

Premier Inc.: Balancing Restructuring Challenges with Positive Performance Services Uptake

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gilead Sciences (GILD – Research Report) and Premi...

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD) and Premier (PINC)

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Premier</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pinc-stock-quote/"><strong>PINC</strong></a></span>) just reported results for the fourth quarter of 2024.</p><ul><li>Premier reported earnings per share of 69 cents. This was above the analyst estimate for EPS of 49 cents.</li><li>The company reported revenue of $350.27 million.</li><li>This was 11.83% better than the analyst estimate for revenue of $313.21 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div>	<p>The post <a href="https://investorplace.com/earning-results/2024/08/pinc-stock-earnings-premier-for-q4-of-2024/">PINC Stock Earnings: Premier Beats EPS, Beats Revenue for Q4 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Premier Inc rating downgraded on FY25-26 guidance miss at Benchmark

These stocks are expected to benefit from the reshoring trend currently happening

CAMT

FLEX

GILD

NVMI

RSHO

STAG

STLD

VEEV

Press Releases

Premier, Inc. Declares Quarterly Cash Dividend

Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results

Premier, Inc. Announces Cross-Industry Initiative to Improve Diagnosis and Care for Chronic Kidney Disease

Premier, Inc. to Participate in BofA Securities Healthcare Conference on May 14, 2024

Premier's PINC AI™ and Fortune Name the Nation's 15 Top Health Systems™

Premier, Inc. to Report Fiscal 2024 Fourth-Quarter and Full-Year Results and Host Conference Call on August 20, 2024

AllSpire Health Partners Selects Premier, Inc. as its National GPO

Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results

Premier, Inc. Appoints Glenn Coleman as Chief Administrative and Financial Officer

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Premier

Premier (PINC) Forecast

Premier (NASDAQ:PINC) Stock, Quote.Headers.trade-ideas